NewAmsterdam Pharma Company had a revenue of 348.00K in the quarter ending Sep 30, 2025, with -98.18%. This bring the company's revenue in the last twelve months to 35.24M, Increased -44.94%. In the fiscal year ending Dec 31, 2024, NewAmsterdam Pharma Company had annual revenue of 45.56M with 223.37% growth.